Does LIFILEUCEL Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with LIFILEUCEL (AMTAGVI). This represents 4.0% of all adverse event reports for LIFILEUCEL.
8
Reports of Malignant neoplasm progression with LIFILEUCEL
4.0%
of all LIFILEUCEL reports
4
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LIFILEUCEL?
Of the 8 reports, 4 (50.0%) resulted in death, 3 (37.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIFILEUCEL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LIFILEUCEL Cause?
Pyrexia (30)
Hypotension (25)
Cytokine release syndrome (18)
Chills (16)
Hypoxia (16)
Acute kidney injury (15)
Atrial fibrillation (14)
Malaise (14)
Pancytopenia (14)
Multiple organ dysfunction syndrome (12)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LIFILEUCEL Alternatives Have Lower Malignant neoplasm progression Risk?
LIFILEUCEL vs LIFITEGRAST
LIFILEUCEL vs LIMAPROST
LIFILEUCEL vs LINACLOTIDE
LIFILEUCEL vs LINAGLIPTIN
LIFILEUCEL vs LINAGLIPTIN\METFORMIN